As a work of reportage, Off the Scales does a wonderful job of explaining the origins of Ozempic and other GLP-1 drugs and ...

Influencer Sabrina Chazen says she struggled emotionally when the GLP-1 drug she tried didn't lead to significant weight loss ...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in ...

Eli Lilly announced Phase 3 trials results for its daily, oral GLP-1 drug. Drugmaker Eli Lilly says its oral, daily GLP-1 pill may offer similar weight loss results as weekly GLP-1 shots. Eli Lilly, ...

The investigational GLP-1 receptor agonist MET-097i, which may be able to be dosed just once a month, yielded weight loss of up to 14.1% by week 28 with class-leading tolerability in a phase IIb trial ...

Oral weight-loss pills will be replacing GLP-1 shots by March 2026, Medicare and Medicaid Services Administrator Dr. Mehmet Oz predicted on Monday. Oz made the statement during a Monday morning ...

A new logo, typeface and dedicated GLP-1 medical program follow the company filing for bankruptcy in May following subscriber losses.

Three Connecticut companies are receiving letters from Attorney General William Tong this month, ordering them to stop ...

Apart from their widely celebrated effect at weight loss and diabetes management, GLP-1 drugs like Ozempic and Wegovy might also reduce alcohol use. In a pilot study published in Scientific Reports, ...

GLP-1 weight-loss drugs are reshaping how many Americans approach Thanksgiving, as the medications curb hunger and make heavy dishes less appealing. Some consider delaying injections to boost appetite ...

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...

The device, OKV-119, is a GLP-1 implant, or a small device inserted under the skin that can deliver doses of medication for ...